SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-131717
Filing Date
2017-04-21
Accepted
2017-04-21 10:49:03
Documents
3
Period of Report
2017-04-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d345988d8k.htm 8-K 16420
2 EX-99.1 d345988dex991.htm EX-99.1 10394
3 GRAPHIC g345988g0421191152184.jpg GRAPHIC 2587
  Complete submission text file 0001193125-17-131717.txt   31757
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 17774562
SIC: 2834 Pharmaceutical Preparations